Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
Fischer C, Deutsch TM, Feisst M, Rippinger N, Riedel F, Hartkopf AD, Brucker SY, Domschke C, Fremd C, Michel L, Burwinkel B, Schneeweiss A, Turchinovich A, Wallwiener M.
Fischer C, et al. Among authors: brucker sy.
Arch Gynecol Obstet. 2022 Sep;306(3):875-885. doi: 10.1007/s00404-022-06442-2. Epub 2022 Mar 2.
Arch Gynecol Obstet. 2022.
PMID: 35237856
Free PMC article.